Marc Girard
- Pathology and Forensic Medicine top 1%
- Rheumatology top 2%
- Oncology top 10%
- Neurology top 5%
- Immunology top 10%
- Co-authors
- Pierre DuquetteJames DarnellDavid BaltimoreLouise CharestJ PleinesCaroline MasseDaniel MarcMichèle Bouloy
- Topics
- Multiple Sclerosis Research Studies (11 papers)Viral Infections and Immunology Research (8 papers)Polyomavirus and related diseases (6 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
Marc Girard
27 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Pathology and Forensic Medicine 1.0k
- Rheumatology 398
- Oncology 394
- Neurology 372
- Immunology 348
Countries citing papers authored by Marc Girard
This map shows the geographic impact of Marc Girard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Girard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Girard more than expected).
Fields of papers citing papers by Marc Girard
This network shows the impact of papers produced by Marc Girard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Girard. The network helps show where Marc Girard may publish in the future.
Co-authorship network of co-authors of Marc Girard
This figure shows the co-authorship network connecting the top 25 collaborators of Marc Girard. A scholar is included among the top collaborators of Marc Girard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Girard. Marc Girard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 9 | |
| 4 | 10 | |
| 5 | 6 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 36 | |
| 9 | 62 | |
| 10 | 122 | |
| 11 | 3 | |
| 12 | Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.breakdown → | 1014 |
| 13 | 29 | |
| 14 | 43 | |
| 15 | 72 | |
| 16 | 18 | |
| 17 | 21 | |
| 18 | 20 | |
| 19 | 1 | |
| 20 | 119 |
About Marc Girard
Marc Girard is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Oncology, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (11 papers), Viral Infections and Immunology Research (8 papers) and Polyomavirus and related diseases (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.0k citations), Rheumatology (398 citations) and Neurology (372 citations). Marc Girard has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Pierre Duquette, James Darnell, David Baltimore, Louise Charest, J Pleines, Caroline Masse, Daniel Marc, Michèle Bouloy, Katherine M. Kean and Enric Tello. Their work appears in journals such as Nucleic Acids Research, Journal of Molecular Biology and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.